Enhancing the study on antithrombotic therapy after stroke in AF patients
- PMID: 38836620
- PMCID: PMC11163302
- DOI: 10.1093/europace/euae147
Enhancing the study on antithrombotic therapy after stroke in AF patients
Conflict of interest statement
Conflict of interest: There is no conflict of interest to disclose.
Similar articles
-
Atrial fibrillation: stroke prevention in older adults.Clin Geriatr Med. 2012 Nov;28(4):617-34. doi: 10.1016/j.cger.2012.08.003. Clin Geriatr Med. 2012. PMID: 23101573 Review.
-
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Chest. 2012 Feb;141(2 Suppl):e531S-e575S. doi: 10.1378/chest.11-2304. Chest. 2012. PMID: 22315271 Free PMC article.
-
Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: assessment of stroke and bleeding risk.J Clin Pharm Ther. 2016 Jun;41(3):279-84. doi: 10.1111/jcpt.12385. Epub 2016 Apr 7. J Clin Pharm Ther. 2016. PMID: 27062272
-
[Your patient needs antithrombotic drugs, 7. Averting the risk of stroke: with whom and how?].MMW Fortschr Med. 2013 Jul 25;155(13):24. doi: 10.1007/s15006-013-1123-6. MMW Fortschr Med. 2013. PMID: 23964495 German. No abstract available.
-
Antithrombotic therapy for stroke prevention in patients with atrial fibrillation in Japan.Expert Opin Pharmacother. 2020 Dec;21(17):2115-2124. doi: 10.1080/14656566.2020.1799976. Epub 2020 Aug 4. Expert Opin Pharmacother. 2020. PMID: 32749891 Review.
References
-
- Breitenstein A, Gay A, Vogtlander K, Fox KAA, Steffel J, Committee XP. The net clinical outcome of dual-pathway inhibition in clinical practice: the “Xarelto plus acetylsalicylic acid: treatment patterns and outcomes in patients with atherosclerosis”. registry. J Clin Med 2024;13:1956. - PMC - PubMed
-
- Fanola CL, Giugliano RP, Ruff CT, Trevisan M, Nordio F, Mercuri MF et al. A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial. Eur Heart J 2017;38:888–96. - PubMed
-
- Gencer B, Eisen A, Berger D, Nordio F, Murphy SA, Grip LT et al. Edoxaban versus Warfarin in high-risk patients with atrial fibrillation: a comprehensive analysis of high-risk subgroups. Am Heart J 2022;247:24–32. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical